http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110870852-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ad79b70063a711180e870ac6eeac554
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
filingDate 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6934c8aa7e495209d652fe8e562bd406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f0ddcd19c0f5062ac93032ac817a91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_421aa601cfa5e711427f4a600377caa8
publicationDate 2020-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110870852-A
titleOfInvention Preparation method of obeticholic acid liposome tablet
abstract The invention discloses a preparation method of an obeticholic acid liposome tablet, which is characterized in that the obeticholic acid liposome consists of obeticholic acid, lecithin and cholesterol, and then the obeticholic acid liposome and proper auxiliary materials are prepared into the obeticholic acid liposome tablet. The obeticholic acid liposome comprises the following components: 1 part of obeticholic acid, 5-10 parts of lecithin and 1-5 parts of cholesterol. Obeticholic acid liposome tablet contains the following components: 1 part of obeticholic acid liposome, 1-5 parts of filler, 0-0.5 part of disintegrating agent, 0-0.5 part of adhesive and 0-0.2 part of lubricant. The technical scheme of the invention utilizes the advantages of the liposome, improves the drug absorption and utilization of obeticholic acid, and can effectively reduce the administration dosage.
priorityDate 2018-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408068020
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783739
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87730
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100052888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25428
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13122
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID486962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID464191
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526254
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID394148
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID510507
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450364447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968404
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449454525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409704282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25203916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID414834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448178750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953

Total number of triples: 76.